Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 99

1.

Associations of Arterial Stiffness Indices with Measures of Insulin Resistance and Renal Sodium Reabsorption.

Ben-Dov IZ, Bursztyn M.

Am J Hypertens. 2019 May 20. pii: hpz082. doi: 10.1093/ajh/hpz082. [Epub ahead of print] No abstract available.

PMID:
31107946
2.

Prognostic Value of Masked Uncontrolled Hypertension.

Pierdomenico SD, Pierdomenico AM, Coccina F, Clement DL, De Buyzere ML, De Bacquer DA, Ben-Dov IZ, Vongpatanasin W, Banegas JR, Ruilope LM, Thijs L, Staessen JA.

Hypertension. 2018 Oct;72(4):862-869. doi: 10.1161/HYPERTENSIONAHA.118.11499.

PMID:
30354717
3.

Evaluation of methodologies for microRNA biomarker detection by next generation sequencing.

Coenen-Stass AML, Magen I, Brooks T, Ben-Dov IZ, Greensmith L, Hornstein E, Fratta P.

RNA Biol. 2018;15(8):1133-1145. doi: 10.1080/15476286.2018.1514236. Epub 2018 Sep 18.

4.

Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.

Mazeh H, Deutch T, Karas A, Bogardus KA, Mizrahi I, Gur-Wahnon D, Ben-Dov IZ.

Cancer Epidemiol Biomarkers Prev. 2018 Aug;27(8):858-863. doi: 10.1158/1055-9965.EPI-18-0055. Epub 2018 Jul 26.

PMID:
30049841
5.

Retrospective MicroRNA Sequencing: Complementary DNA Library Preparation Protocol Using Formalin-fixed Paraffin-embedded RNA Specimens.

Loudig O, Liu C, Rohan T, Ben-Dov IZ.

J Vis Exp. 2018 May 5;(135). doi: 10.3791/57471.

PMID:
29781987
6.

Human plasma and serum extracellular small RNA reference profiles and their clinical utility.

Max KEA, Bertram K, Akat KM, Bogardus KA, Li J, Morozov P, Ben-Dov IZ, Li X, Weiss ZR, Azizian A, Sopeyin A, Diacovo TG, Adamidi C, Williams Z, Tuschl T.

Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):E5334-E5343. doi: 10.1073/pnas.1714397115. Epub 2018 May 18.

7.

The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation.

Nechama M, Kwon J, Wei S, Kyi AT, Welner RS, Ben-Dov IZ, Arredouani MS, Asara JM, Chen CH, Tsai CY, Nelson KF, Kobayashi KS, Israel E, Zhou XZ, Nicholson LK, Lu KP.

Nat Commun. 2018 Apr 23;9(1):1603. doi: 10.1038/s41467-018-03886-6.

8.

Adrenocorticotropic Hormone Secreting Pheochromocytoma Underlying Glucocorticoid Induced Pheochromocytoma Crisis.

Geva GA, Gross DJ, Mazeh H, Atlan K, Ben-Dov IZ, Fischer M.

Case Rep Endocrinol. 2018 Feb 20;2018:3963274. doi: 10.1155/2018/3963274. eCollection 2018.

9.

Urine cell-free microRNA as biomarkers for transitional cell carcinoma.

Geva GA, Gielchinsky I, Aviv N, Max KEA, Gofrit ON, Gur-Wahnon D, Ben-Dov IZ.

BMC Res Notes. 2017 Nov 29;10(1):641. doi: 10.1186/s13104-017-2950-9.

10.

Plasma microRNA profiling: Exploring better biomarkers for lymphoma surveillance.

Khare D, Goldschmidt N, Bardugo A, Gur-Wahnon D, Ben-Dov IZ, Avni B.

PLoS One. 2017 Nov 13;12(11):e0187722. doi: 10.1371/journal.pone.0187722. eCollection 2017.

11.

Association of Blood Pressure Variability Ratio With Glomerular Filtration Rate Independent of Blood Pressure and Pulse Wave Velocity.

Woodiwiss AJ, Norton GR, Ben-Dov IZ, Gavish B, Bursztyn M.

Am J Hypertens. 2017 Nov 6;30(12):1177-1188. doi: 10.1093/ajh/hpx122.

PMID:
28992192
12.

Alterations of microRNAs throughout the malignant evolution of cutaneous squamous cell carcinoma: the role of miR-497 in epithelial to mesenchymal transition of keratinocytes.

Mizrahi A, Barzilai A, Gur-Wahnon D, Ben-Dov IZ, Glassberg S, Meningher T, Elharar E, Masalha M, Jacob-Hirsch J, Tabibian-Keissar H, Barshack I, Roszik J, Leibowitz-Amit R, Sidi Y, Avni D.

Oncogene. 2018 Jan 11;37(2):218-230. doi: 10.1038/onc.2017.315. Epub 2017 Sep 18.

PMID:
28925390
13.

Schistosomal MicroRNAs Isolated From Extracellular Vesicles in Sera of Infected Patients: A New Tool for Diagnosis and Follow-up of Human Schistosomiasis.

Meningher T, Lerman G, Regev-Rudzki N, Gold D, Ben-Dov IZ, Sidi Y, Avni D, Schwartz E.

J Infect Dis. 2017 Feb 1;215(3):378-386. doi: 10.1093/infdis/jiw539.

PMID:
28362903
14.

Evaluation and Adaptation of a Laboratory-Based cDNA Library Preparation Protocol for Retrospective Sequencing of Archived MicroRNAs from up to 35-Year-Old Clinical FFPE Specimens.

Loudig O, Wang T, Ye K, Lin J, Wang Y, Ramnauth A, Liu C, Stark A, Chitale D, Greenlee R, Multerer D, Honda S, Daida Y, Spencer Feigelson H, Glass A, Couch FJ, Rohan T, Ben-Dov IZ.

Int J Mol Sci. 2017 Mar 14;18(3). pii: E627. doi: 10.3390/ijms18030627.

15.

ALS Along the Axons - Expression of Coding and Noncoding RNA Differs in Axons of ALS models.

Rotem N, Magen I, Ionescu A, Gershoni-Emek N, Altman T, Costa CJ, Gradus T, Pasmanik-Chor M, Willis DE, Ben-Dov IZ, Hornstein E, Perlson E.

Sci Rep. 2017 Mar 16;7:44500. doi: 10.1038/srep44500.

16.

Let-7 and MicroRNA-148 Regulate Parathyroid Hormone Levels in Secondary Hyperparathyroidism.

Shilo V, Mor-Yosef Levi I, Abel R, Mihailović A, Wasserman G, Naveh-Many T, Ben-Dov IZ.

J Am Soc Nephrol. 2017 Aug;28(8):2353-2363. doi: 10.1681/ASN.2016050585. Epub 2017 Mar 15.

17.

H19 non-coding RNA in urine cells detects urothelial carcinoma: a pilot study.

Gielchinsky I, Gilon M, Abu-Lail R, Matouk I, Hochberg A, Gofrit ON, Ben-Dov IZ.

Biomarkers. 2017 Nov;22(7):661-666. doi: 10.1080/1354750X.2016.1276625. Epub 2017 Mar 22.

PMID:
28067543
18.

The gut microbiome and hypertension.

Pevsner-Fischer M, Blacher E, Tatirovsky E, Ben-Dov IZ, Elinav E.

Curr Opin Nephrol Hypertens. 2017 Jan;26(1):1-8. Review.

PMID:
27798455
19.

Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO).

Vaknin-Dembinsky A, Charbit H, Brill L, Abramsky O, Gur-Wahnon D, Ben-Dov IZ, Lavon I.

J Neuroinflammation. 2016 Jul 8;13(1):179. doi: 10.1186/s12974-016-0648-x.

20.

Cell and Microvesicle Urine microRNA Deep Sequencing Profiles from Healthy Individuals: Observations with Potential Impact on Biomarker Studies.

Ben-Dov IZ, Whalen VM, Goilav B, Max KE, Tuschl T.

PLoS One. 2016 Jan 19;11(1):e0147249. doi: 10.1371/journal.pone.0147249. eCollection 2016.

21.

Aortic Pulse Pressure Amplification Imputed From Simple Clinical Measures Adds to the Ability of Brachial Pressure to Predict Survival.

Bursztyn M, Norton GR, Ben-Dov IZ, Booysen HL, Sibiya MJ, Sareli P, Woodiwiss AJ.

Am J Hypertens. 2016 Jun;29(6):754-62. doi: 10.1093/ajh/hpv176. Epub 2015 Nov 4.

PMID:
26541569
22.

Dysregulated miRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS.

Emde A, Eitan C, Liou LL, Libby RT, Rivkin N, Magen I, Reichenstein I, Oppenheim H, Eilam R, Silvestroni A, Alajajian B, Ben-Dov IZ, Aebischer J, Savidor A, Levin Y, Sons R, Hammond SM, Ravits JM, Möller T, Hornstein E.

EMBO J. 2015 Nov 3;34(21):2633-51. doi: 10.15252/embj.201490493. Epub 2015 Sep 1.

23.

Parathyroid-specific deletion of dicer-dependent microRNAs abrogates the response of the parathyroid to acute and chronic hypocalcemia and uremia.

Shilo V, Ben-Dov IZ, Nechama M, Silver J, Naveh-Many T.

FASEB J. 2015 Sep;29(9):3964-76. doi: 10.1096/fj.15-274191. Epub 2015 Jun 8.

PMID:
26054367
24.

Lowering the quantification limit of the QubitTM RNA HS assay using RNA spike-in.

Li X, Ben-Dov IZ, Mauro M, Williams Z.

BMC Mol Biol. 2015 May 6;16:9. doi: 10.1186/s12867-015-0039-3.

25.

MicroRNA-21 in glomerular injury.

Lai JY, Luo J, O'Connor C, Jing X, Nair V, Ju W, Randolph A, Ben-Dov IZ, Matar RN, Briskin D, Zavadil J, Nelson RG, Tuschl T, Brosius FC 3rd, Kretzler M, Bitzer M.

J Am Soc Nephrol. 2015 Apr;26(4):805-16. doi: 10.1681/ASN.2013121274. Epub 2014 Aug 21.

26.

Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline.

Ben-Dov IZ, Tan YC, Morozov P, Wilson PD, Rennert H, Blumenfeld JD, Tuschl T.

PLoS One. 2014 Jan 29;9(1):e86856. doi: 10.1371/journal.pone.0086856. eCollection 2014.

27.

Comparison of systolic blood pressure values obtained by photoplethysmography and by Korotkoff sounds.

Nitzan M, Adar Y, Hoffman E, Shalom E, Engelberg S, Ben-Dov IZ, Bursztyn M.

Sensors (Basel). 2013 Oct 31;13(11):14797-812. doi: 10.3390/s131114797.

28.

A cautious view of the relationship between ambulatory blood pressure monitoring data and salt-sensitivity of blood pressure. Reply.

Bursztyn M, Ben-Dov IZ.

J Hypertens. 2013 Sep;31(9):1910. doi: 10.1097/HJH.0b013e3283635270. No abstract available.

PMID:
24107667
29.

HYVET ambulatory blood pressure substudy.

Ben-Dov IZ, Bursztyn M.

Hypertension. 2013 May;61(5):e42. doi: 10.1161/HYPERTENSIONAHA.111.00884. Epub 2013 Mar 4. No abstract available.

PMID:
23460282
30.

Sex differences in salt-sensitivity risk approximated from ambulatory blood pressure monitoring and mortality.

Bursztyn M, Ben-Dov IZ.

J Hypertens. 2013 May;31(5):900-5. doi: 10.1097/HJH.0b013e32835f29f4.

PMID:
23449016
31.

Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations.

Williams Z, Ben-Dov IZ, Elias R, Mihailovic A, Brown M, Rosenwaks Z, Tuschl T.

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4255-60. doi: 10.1073/pnas.1214046110. Epub 2013 Feb 25.

32.

Reprogramming of the microRNA transcriptome mediates resistance to rapamycin.

Totary-Jain H, Sanoudou D, Ben-Dov IZ, Dautriche CN, Guarnieri P, Marx SO, Tuschl T, Marks AR.

J Biol Chem. 2013 Mar 1;288(9):6034-44. doi: 10.1074/jbc.M112.416446. Epub 2013 Jan 8.

33.

MicroRNA sequence profiles of human kidney allografts with or without tubulointerstitial fibrosis.

Ben-Dov IZ, Muthukumar T, Morozov P, Mueller FB, Tuschl T, Suthanthiran M.

Transplantation. 2012 Dec 15;94(11):1086-94. doi: 10.1097/TP.0b013e3182751efd.

34.

Microparticles and microRNAs of endothelial progenitor cells ameliorate acute kidney injury.

Bitzer M, Ben-Dov IZ, Thum T.

Kidney Int. 2012 Aug;82(4):375-7. doi: 10.1038/ki.2012.152.

35.

Bioinformatic analysis of barcoded cDNA libraries for small RNA profiling by next-generation sequencing.

Farazi TA, Brown M, Morozov P, Ten Hoeve JJ, Ben-Dov IZ, Hovestadt V, Hafner M, Renwick N, Mihailović A, Wessels LF, Tuschl T.

Methods. 2012 Oct;58(2):171-87. doi: 10.1016/j.ymeth.2012.07.020. Epub 2012 Jul 23.

36.

Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients.

Bleumin D, Cohen MJ, Moranne O, Esnault VL, Benenson S, Paltiel O, Tzukert K, Mor-Yosef Levi I, Ben-Dov IZ, Levi R, Bloch A, Haviv YS.

J Infect. 2012 Oct;65(4):318-25. doi: 10.1016/j.jinf.2012.06.005. Epub 2012 Jun 18.

PMID:
22722020
37.

Association of heart rate with blood pressure variability: implications for blood pressure measurement.

Cahan A, Ben-Dov IZ, Bursztyn M.

Am J Hypertens. 2012 Mar;25(3):313-8. doi: 10.1038/ajh.2011.230. Epub 2011 Dec 8.

PMID:
22158064
38.

Transjugular kidney biopsy: enabling safe tissue diagnosis in high risk patients.

Levi IM, Ben-Dov IZ, Klimov A, Pizov G, Bloom AI.

Isr Med Assoc J. 2011 Jul;13(7):425-7.

39.

Intervisit blood pressure variability and outcome: is heart rate a missing confounder?

Ben-Dov IZ, Cahan A, Bursztyn M.

Hypertension. 2011 Jul;58(1):e1; author reply e2. doi: 10.1161/HYPERTENSIONAHA.111.173641. Epub 2011 May 16. No abstract available.

PMID:
21576626
40.

The prognostic value of changes in serum ferritin levels during therapy for hepatitis C virus infection.

Ackerman Z, Pappo O, Ben-Dov IZ.

J Med Virol. 2011 Jul;83(7):1262-8. doi: 10.1002/jmv.22093.

PMID:
21567428
41.

Referral of women to ambulatory blood pressure monitoring.

Ben-Dov IZ, Bursztyn M.

Hypertension. 2011 Jun;57(6):e26; author reply e27. doi: 10.1161/HYPERTENSIONAHA.111.172759. Epub 2011 Apr 25. No abstract available.

PMID:
21518962
42.

The morning blood pressure surge and all-cause mortality in patients referred for ambulatory blood pressure monitoring.

Israel S, Israel A, Ben-Dov IZ, Bursztyn M.

Am J Hypertens. 2011 Jul;24(7):796-801. doi: 10.1038/ajh.2011.58. Epub 2011 Apr 14.

PMID:
21490694
43.

Serum uric acid is a GFR-independent long-term predictor of acute and chronic renal insufficiency: the Jerusalem Lipid Research Clinic cohort study.

Ben-Dov IZ, Kark JD.

Nephrol Dial Transplant. 2011 Aug;26(8):2558-66. doi: 10.1093/ndt/gfq740. Epub 2011 Jan 10.

44.

Can salt sensitivity of blood pressure be assessed without changing salt diet?

Ben-Dov IZ, Bursztyn M.

Hypertension. 2011 Feb;57(2):156-7. doi: 10.1161/HYPERTENSIONAHA.110.163881. Epub 2011 Jan 3. No abstract available.

PMID:
21199996
45.

Intensive blood-pressure control in hypertensive chronic kidney disease.

Bursztyn M, Ben-Dov IZ.

N Engl J Med. 2010 Dec 23;363(26):2564; author reply 2565-6. doi: 10.1056/NEJMc1011419. No abstract available.

PMID:
21175326
46.

The role of blood pressure variability in misdiagnosed clinic hypertension.

Cahan A, Ben-Dov IZ, Mekler J, Bursztyn M.

Hypertens Res. 2011 Feb;34(2):187-92. doi: 10.1038/hr.2010.190. Epub 2010 Nov 11.

PMID:
21068739
47.

Increased intervisit blood pressure variability and ß-blockade: measurement imprecision related to bradycardia?

Ben-Dov IZ, Bursztyn M.

Hypertension. 2010 Nov;56(5):e48; author reply e49. doi: 10.1161/HYPERTENSIONAHA.110.160978. Epub 2010 Sep 13. No abstract available.

PMID:
20837878
48.

Acquired DHA nephropathy in rats.

Ben-Dov IZ, Shuvy M.

Nephrol Dial Transplant. 2010 Oct;25(10):3455-6; author reply 3456. doi: 10.1093/ndt/gfq390. Epub 2010 Jul 7. No abstract available.

PMID:
20610528
49.

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.

Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T.

Kidney Int. 2010 Feb;77(3):211-8. doi: 10.1038/ki.2009.464. Epub 2009 Dec 16.

50.

White-coat hypertension should not be treated in subjects with diabetes.

Bursztyn M, Ben-Dov IZ.

Diabetes Care. 2009 Nov;32 Suppl 2:S310-3. doi: 10.2337/dc09-S328. Review. No abstract available.

Supplemental Content

Loading ...
Support Center